QA: Anixa Biosciences Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000715446_2023_Anixa_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0000715446, Anixa Biosciences Inc

  xvar xval
0 AssetsCurrent 30,200,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 212,000
4 LiabilitiesCurrent 2,037,000
5 LiabilitiesNoncurrent 175,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,172,000
9 ResearchAndDevelopmentExpense 6,703,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 104,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 30,412,000
1 Liabilities 2,212,000
2 Expenses 13,875,000
3 Revenues 0
4 StockholdersEquity 28,200,000
5 NetIncome -13,771,000
6 ComprehensiveNetIncome -13,771,000
7 BaseVar 23,301,500
8 EconomicCapitalRatio 2.13

Edgar->Model Mapping

Feature Distribution

Change over Time